Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -224,034
▼ 54% vs 2024
Profit
Caution€ -4 million
▼ 490% vs 2024
Debts
Low€ 1.9 million
▼ 29% vs 2024
CHAGRAL INVEST from Ukkel, company number BE0668490049, closed financial year 2025 with a result of € -4 million after tax. For that financial year CHAGRAL INVEST recorded a gross margin of € -224,034 and equity of € 149.3 million. Compared with financial year 2024, the result moved from € -670,344 to € -4 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
What happened at CHAGRAL INVEST?
What happened at CHAGRAL INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 4 million. Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
- Marc NOLET DE BRAUWERE VAN STEENLAND became a director. NBB
In short
From € 100,429 profit in 2021 to € 4 million loss in 2025.
Paid € 1.4 million in corporate taxes since 2021.
Best year ever: 2021, with € 100,429 profit.
Paid out € 3.6 million in dividends to the owners in total.
A new publication or filing at CHAGRAL INVEST? We notify you, reason included.
Follow CHAGRAL INVESTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CHAGRAL INVEST is Marc NOLET DE BRAUWERE VAN STEENLAND. It owns 99.9% of BAULOU, 49.6% of ENDO TOOLS THERAPEUTICS, 20.4% of SYNERGIA MEDICAL, 18.9% of KIOMED PHARMA and 12.2% of OSIMIS itself.
Directors
According to the 2025 annual accounts
Marc NOLET DE BRAUWERE VAN STEENLAND
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Prins de Lignelaan 121 box 2
1180 Ukkel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0668.490.049
- VAT number
- BE 0668.490.049
- Registered office
- Prins de Lignelaan 121 bus 2, 1180 Ukkel
- Names & denominations
- CHAGRAL INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 2016
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering